Início › Câncer de Mama Triplo-Negativo › Missouri › St. Louis
Ensaios clínicos de Câncer de Mama Triplo-Negativo em St. Louis, MO
21 estudos para Câncer de Mama Triplo-Negativo estão buscando participantes em locais em St. Louis e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Washington University Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecrutandoFase 1
- Washington University School of Medicine in St. Louis, St Louis
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RecrutandoFase 1/2
- Washington University, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecrutandoEstudo observacional
- Washington University, St Louis
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecrutandoFase 3
- Siteman Cancer Center ( Site 0099), St Louis
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecrutandoFase 3
- Washington University Siteman Cancer Center ( Site 0031), St Louis
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- Local Institution - 0140, St Louis
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
RecrutandoFase 1/2
- Washington University, St Louis
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
RecrutandoFase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- e mais 1
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RecrutandoFase 3
- Washington University School of Medicine, St Louis
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RecrutandoEstudo observacional
- Cancer Care Specialist of Illinois, O'Fallon · a 16 mi de distância
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RecrutandoFase 1
- Washington University, St Louis
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Research Site, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RecrutandoFase 1
- Normunity Investigational Site, St Louis
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
RecrutandoFase 1
- Washington University School of Medicine, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
RecrutandoEstudo observacional
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
A Study of LY4175408 in Participants With Advanced Cancer
RecrutandoFase 1
- Washington University, St Louis
Study of XB010 in Subjects With Solid Tumors
RecrutandoFase 1
- Siteman Cancer Center, St Louis
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
RecrutandoFase 1/2
- Siteman Cancer Center, St Louis
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RecrutandoFase 1/2
- Washington University, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- Washington University, St Louis
Ensaios de Câncer de Mama Triplo-Negativo em outras cidades
- Houston, TX42 estudos
- New York City, NY31 estudos
- Nashville, TN28 estudos
- Los Angeles, CA27 estudos
- Boston, MA26 estudos
- San Antonio, TX23 estudos
- Arlington, VA20 estudos
- Atlanta, GA20 estudos
- Dallas, TX18 estudos
- Chicago, IL16 estudos
- Columbus, OH16 estudos
- Grand Rapids, MI15 estudos
Outros estudos em St. Louis
- Câncer de Pulmão de Não Pequenas Células73 estudos
- Câncer de Mama64 estudos
- Câncer Metastático54 estudos
- Câncer Colorretal50 estudos
- Câncer (todos os tipos)46 estudos
- Câncer de Próstata46 estudos
- Câncer de Pulmão39 estudos
- Câncer de Ovário38 estudos
- Câncer de Pâncreas33 estudos
- Câncer Endometrial29 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço28 estudos
- Insuficiência Cardíaca26 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.